Covaxin Booster Dose – Safe and Necessary To Ensure Immunity, Indicates ICMR Study
DBT has supported thousands of people and enhancement of capacities for conducting clinical trials.
Share
Posts by tag
Bharat Biotech
84 posts
Covaxin’s Expanded Approval: Safeguarding Children Aged 6-12 Against COVID-19
Bharat Biotech said it conducted clinical trials in paediatric population between June 2021 to September 2021 and results have shown robust safety, reactogenicity, and immunogenicity.
Share
Covaxin Booster Dose Neutralises Omicron Variant: All You Need To Know
At a time when India is amidst the third wave of COVID-19, which is led by the Omicron variant, there is some good piece of news. A study conducted at…
Share
Covaxin For Kids: Bharat Biotech Says Other Vaccines Reportedly Being Administered To Children
Hyderabad-based vaccine manufacturer Bharat Biotech has said that there are reports that children in the age group of 15-18 years are being administered COVID-19 vaccines that are not authorized for…
Share
Lancet Infectious Diseases Study Compare Well With Phase 3 Clinical Trials Of COVAXIN: Bharat Biotech
On the study conducted by the Lancet Infectious Diseases on the effectiveness of COVAXIN (BBV152) against symptomatic RT-PCR, Bharat Biotech the Hyderabad based company commented and has compared the results…
Share
Diwali Cheer For Bharat Biotech: WHO Grants Emergency Use Listing To Bharat Biotech’s Covaxin
The WHO in a major development on Wednesday announced that it has approved the emergency use listing (EUL) to Bharat Biotech’s COVID-19 vaccine Covaxin. This comes after the Technical Advisory…
Share
We Are Waiting For DCGI Approval For Children’s Covid-19 Vaccine: Bharat Biotech Chairman
Dr. Krishna Ella the chairman and Managing Director of Bharat Biotech on Saturday announced that they are waiting for approval from the Drugs Controller General of India (DCGI) for the…
Share